HK1210718A1 - 抗白癬菌症外用液劑 - Google Patents

抗白癬菌症外用液劑

Info

Publication number
HK1210718A1
HK1210718A1 HK15111656.5A HK15111656A HK1210718A1 HK 1210718 A1 HK1210718 A1 HK 1210718A1 HK 15111656 A HK15111656 A HK 15111656A HK 1210718 A1 HK1210718 A1 HK 1210718A1
Authority
HK
Hong Kong
Prior art keywords
antitrichophytosis
solution
external use
external
antitrichophytosis solution
Prior art date
Application number
HK15111656.5A
Other languages
English (en)
Inventor
吉田佳子
小松千記
．嘉屋
高畑祥
田端祐二
Original Assignee
Meiji Seika Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49995097&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1210718(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Meiji Seika Pharma Co Ltd filed Critical Meiji Seika Pharma Co Ltd
Publication of HK1210718A1 publication Critical patent/HK1210718A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK15111656.5A 2012-07-30 2015-11-26 抗白癬菌症外用液劑 HK1210718A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012069306 2012-07-30
PCT/JP2013/070525 WO2014021282A1 (ja) 2012-07-30 2013-07-30 抗白癬菌症外用液剤

Publications (1)

Publication Number Publication Date
HK1210718A1 true HK1210718A1 (zh) 2016-05-06

Family

ID=49995097

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111656.5A HK1210718A1 (zh) 2012-07-30 2015-11-26 抗白癬菌症外用液劑

Country Status (20)

Country Link
US (1) US20140030209A1 (zh)
EP (1) EP2889031A4 (zh)
JP (1) JP6132842B2 (zh)
KR (1) KR20150038314A (zh)
CN (1) CN104661661A (zh)
AR (1) AR092358A1 (zh)
AU (1) AU2013297602A1 (zh)
BR (1) BR112015001235A2 (zh)
CA (1) CA2879846A1 (zh)
CL (1) CL2015000218A1 (zh)
CO (1) CO7170168A2 (zh)
HK (1) HK1210718A1 (zh)
IL (1) IL236993A0 (zh)
MX (1) MX2015001416A (zh)
PH (1) PH12015500224A1 (zh)
RU (1) RU2015106906A (zh)
SG (1) SG11201500637QA (zh)
TW (1) TW201410239A (zh)
WO (1) WO2014021282A1 (zh)
ZA (1) ZA201500809B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR091934A1 (es) 2012-07-30 2015-03-11 Meiji Seika Pharma Co Ltd Parche para antidermatofitosis
EP3190105A4 (en) 2014-08-13 2018-05-30 Meiji Seika Pharma Co., Ltd. Crystalline anti-trichophyton drug and method for producing same
WO2016148263A1 (ja) * 2015-03-19 2016-09-22 第一三共株式会社 抗酸化剤を含有する固形製剤
JP6630344B2 (ja) 2015-03-19 2020-01-15 第一三共株式会社 着色剤を含有する固形製剤
CN107311838A (zh) * 2017-07-13 2017-11-03 柳州丰康泰科技有限公司 一种新的合成环丙基溴的方法
WO2019150485A1 (ja) * 2018-01-31 2019-08-08 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 爪白癬の予防又は治療用外用液剤

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628892A1 (de) * 1986-08-26 1988-03-10 Bayer Ag Substituierte 1-aryl-3-tert.-butyl-pyrazole
ES2015648A6 (es) 1989-05-05 1990-09-01 Consejo Superior Investigacion Procedeimiento de sintesis de mono y bis (3-r3-4-r4-5-r5-pirazol-1-il)1,4-dihidroxibencenos.
US5391367A (en) * 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution
DE4414897A1 (de) 1994-04-28 1995-11-02 Hoechst Ag Aromatische Diazoniumsalze und deren Verwendung in strahlungsempfindlichen Gemischen
JP3729884B2 (ja) 1995-01-05 2005-12-21 関東電化工業株式会社 フルオロフェノール類の製造方法
JPH1160528A (ja) 1997-08-12 1999-03-02 Ube Ind Ltd ４−クロロ−３−トリフルオロメチルフェノールの製法
EP1144383A1 (en) * 1999-01-14 2001-10-17 Merck Frosst Canada & Co. Synthesis of 4-[(5-substituted or unsubstituted phenyl)-3-substituted-1h-pyrazol-1-yl]benzenesulfonamides
WO2001066513A1 (en) 2000-03-03 2001-09-13 Sumitomo Chemical Company, Limited Process for the preparation of phenylhydrazines
JP2004536845A (ja) 2001-07-11 2004-12-09 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド サイトカイン媒介疾患の治療方法
WO2004033432A1 (ja) * 2002-10-09 2004-04-22 Ssp Co., Ltd. 抗真菌活性を有する新規ピラゾール化合物
KR100509603B1 (ko) * 2002-12-28 2005-08-22 삼성에스디아이 주식회사 적색 발광 화합물 및 이를 채용한 유기 전계 발광 소자
NZ542904A (en) * 2003-03-21 2009-04-30 Nexmed Holdings Inc Antifungal nail coat and method of use
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
ATE510836T1 (de) 2006-01-19 2011-06-15 Matrix Lab Ltd Umwandlung eines aromatischen diazoniumsalzes in ein arylhydrazin
WO2008024978A2 (en) * 2006-08-24 2008-02-28 Serenex, Inc. Tetrahydroindolone and tetrahydroindazolone derivatives
CN101011560A (zh) * 2007-02-13 2007-08-08 贵州神奇集团控股有限公司 治疗脚手癣、灰指甲的中西复方制剂及其制备方法和质控方法
CN103339112B (zh) * 2011-01-30 2015-08-12 明治制果药业株式会社 外用抗真菌剂

Also Published As

Publication number Publication date
PH12015500224A1 (en) 2015-04-06
JP6132842B2 (ja) 2017-05-24
AR092358A1 (es) 2015-04-15
IL236993A0 (en) 2015-03-31
BR112015001235A2 (pt) 2017-07-04
EP2889031A4 (en) 2016-01-06
SG11201500637QA (en) 2015-03-30
CN104661661A (zh) 2015-05-27
CA2879846A1 (en) 2014-02-06
CL2015000218A1 (es) 2015-05-22
EP2889031A1 (en) 2015-07-01
CO7170168A2 (es) 2015-01-28
TW201410239A (zh) 2014-03-16
KR20150038314A (ko) 2015-04-08
MX2015001416A (es) 2015-05-08
AU2013297602A1 (en) 2015-02-19
WO2014021282A1 (ja) 2014-02-06
US20140030209A1 (en) 2014-01-30
JPWO2014021282A1 (ja) 2016-07-21
ZA201500809B (en) 2016-04-28
RU2015106906A (ru) 2016-09-20

Similar Documents

Publication Publication Date Title
HK1245780B (zh) 咪唑並吡咯烷酮化合物
HK1203498A1 (zh) 四氫吡唑並嘧啶化合物
EP2925129A4 (en) PRO-NEUROGENIC COMPOUNDS
GB201209138D0 (en) Compounds
GB201214750D0 (en) Compounds
GB201215357D0 (en) Compounds
EP2887803A4 (en) PRO-NEUROGENIC COMPOUNDS
HK1206726A1 (zh) 咪唑並三嗪酮化合物
GB201204985D0 (en) Compounds
HK1210709A1 (zh) 外用組合物
GB201204125D0 (en) Compounds
GB201216800D0 (en) Novel use
HK1211283A1 (zh) 化合物
HK1210718A1 (zh) 抗白癬菌症外用液劑
GB201209096D0 (en) Compounds
HK1206356A1 (zh) -取代的氰基吡唑化合物
GB201219820D0 (en) Compounds
GB201217310D0 (en) Compounds
GB201214413D0 (en) Festivalstand (festistand)
GB201206393D0 (en) Use
GB201212463D0 (en) Novel use
GB201216763D0 (en) Blokprintz (wallblocks)
GB201202256D0 (en) Novel use
GB201223429D0 (en) Compounds
GB201203779D0 (en) (LASERComfortSET)